Pacific Therapeutics Signs Definative Agreement Sample Contracts

PACIFIC THERAPEUTICS SIGNS DEFINATIVE AGREEMENT TO SELL FIBROSIS AND ERECTILE DYSFUNCTION THERAPEUTICS TECHNOLOGIES

Pacific Therapeutics Signs Definative Agreement • April 7th, 2017 • Tower One Wireless Corp. • Pharmaceutical preparations

• Contract Type
  Pacific Therapeutics Signs Definative Agreement
• Filed
  April 7th, 2017
• Company
  Tower One Wireless Corp.
• Industry
  Pharmaceutical preparations

VANCOUVER, BC, Canada –July 24, 2015 – Pacific Therapeutics Ltd. (CSE: PT) (OTC Markets: PCFTF) (Frankfurt: 1P3) (the “Company”) is a clinical stage specialty pharmaceutical company focused on the repurposing and reformulation of existing FDA approved drugs for large markets. The Company’s research programs have focused on diseases of excessive scarring (fibrosis) and erectile dysfunction (ED).